Nutritional boost may speed muscle recovery in seniors after exercise
NCT ID NCT06205537
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a combination of nutritional ingredients can help healthy older adults (ages 60–75) recover muscle strength and reduce soreness after a short, intense exercise session. Thirty participants were randomly assigned to receive either the nutrient blend or a placebo, and researchers measured leg strength, fatigue, and muscle soreness. The goal was to see if these nutrients could support faster recovery and better muscle health in aging adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Aug 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult participant, male and female (≥60 and ≤75 years of age) * Subject is ambulatory * Body mass index (BMI) \>18.5 but \<30 kg/m2 * Subject agrees to refrain from starting an exercise program throughout the trial * Has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), and applicable privacy regulation authorization prior to any participation in the study * Willingness to follow the protocol as described, including consumption of study product per the protocol, and completing any forms/questionnaires needed throughout the study Exclusion Criteria: * Subject reports having type 1 or type 2 diabetes * Subject reports having undergone major surgery that might affect the outcomes * Has stated presence of partial or full lower artificial limb * Is unable to participate in an exercise protocol * Habitually engages in strenuous exercise, duration of 1 hour or longer, 3 or more times per week * Subjects has received systemic corticosteroid treatment in the last 3 months * Subject reports recent oral antibiotic use * Subject reports of current active malignant disease, except basal or squamous cell skin carcinoma or carcinoma in situ of the uterine cervix * Subject reports of significant cardiovascular event within 6 months prior to study entry or history of congestive heart failure * Subject reports of end-stage organ failure or is post-organ transplant * Subject reports of current or history of renal disease or severe gastroparesis * Subject reports of current diagnosed hepatic disease * Subject reports of history of GI disease that could impact digestion or absorption of the study product * Subject reports a history of autoimmune or connective tissue diseases that may affect muscle. * Subject reports clotting or bleeding disorders. * Subject reports a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis A, B or C, or HIV. * Subjects reports an eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures * Subject reports having statin-induced myopathy at time of screening. * Subject reports taking certain dietary supplements, oral nutritional supplements or high protein nutritional supplements, or medications, that could profoundly affect muscle metabolism. Exceptions for multi-vitamin/mineral supplement and inhaled steroids for asthma, topical or optical steroids. Those users who can stop using such products for ≥4 weeks before baseline visit and agree to refrain from taking them over the study period need not be excluded. * Subject cannot refrain from using specific oils in their home cooked meals over the course of the study. * Has an allergy or intolerance to any ingredient in the study product. * Participates in another study that has not been approved as a concomitant study by Abbott Nutrition. * Subject has participated in another research study in the last 3 months that involved an inconvenience allowance or biosampling (including \>50ml blood or any tissue samples).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Exercise induced muscle damage are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Nottingham
Derby, DE22 3DT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can a berry extract help athletes bounce back after brutal workouts?
- Turmeric's curcumin vs. ibuprofen: a natural path to faster muscle recovery?
- Can a peptide gummy soothe sore muscles and speed recovery?
- Rest between sets: the secret to stronger workouts without the pain?
- Mushroom timing may boost athletic recovery